Total and free serum concentrations of thyroxine and triiodothyronine were measured in 122 subjects with hypothyroidism who were clinically well while receiving conventional replacement treatment with thyroxine. In a third of patients concentrations of total and free thyroxine were raised, often considerably; nevertheless concentrations of total and free triiodothyronine were usually normal. Though significant correlations were obtained between total triiodothyronine concentrations and total thyroxine concentrations (p <0 001) and between the triiodothyronine concentrations and free thyroxine concentrations (p<0001) the slope of the line of the regression equation describing these correlations was small, hence large increases in both total and free thyroxine concentrations were accompanied by only modest increases in total and free triiodothyronine concentrations.
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Total and free thyroid hormone concentrations in patients receiving maintenance replacement treatment with thyroxine C J PEARCE, R L HIMSWORTH Abstract Total and free serum concentrations of thyroxine and triiodothyronine were measured in 122 subjects with hypothyroidism who were clinically well while receiving conventional replacement treatment with thyroxine. In a third of patients concentrations of total and free thyroxine were raised, often considerably; nevertheless concentrations of total and free triiodothyronine were usually normal. Though significant correlations were obtained between total triiodothyronine concentrations and total thyroxine concentrations (p <0 001) and between the triiodothyronine concentrations and free thyroxine concentrations (p<0001) the slope of the line of the regression equation describing these correlations was small, hence large increases in both total and free thyroxine concentrations were accompanied by only modest increases in total and free triiodothyronine concentrations.
The presence of total or free thyroxine concentrations above normal in patients taking thyroxine therefore are not necessarily ofclinical consequence. In the assessment of adequacy of replacement treatment with thyroxine the most logical combination of in vitro thyroid function test results may be a normal thyrotrophin concentration and normal free triiodothyronine concentration.
Introduction
Hypothyroidism is a common disorder' and practitioners in all specialties will encounter such patients who are treated with thyroxine. Though the efficacy of replacement treatment is without doubt, the niceties of dose regulation are still imperfectly understood despite the introduction of radioimmunoassays for the precise measurement of the concentration of hormones in serum. The interpretation of results of assays for total thyroxine concentration is complicated, firstly because the hormones are largely protein bound, and it is the concentration of free hormone that is physiologically important, and secondly because the conversion of thyroxine to the biologically effective triiodothyronine is now recognised as a crucial stage in the expression of thyroid hormone activity.
The original treatment for hypothyroidism was thyroid extract, a variable mixture of thyroxine and triiodothyronine, but this has now been superseded in Britain by pure synthetic thyroxine. For many years it was accepted practice to prescribe thyroxine in doses from 200 to 400 ,ug daily. With the introduction of radioimmunoassay it was found that total plasma thyroxine concentrations in patients receiving these doses might be comparable to those in patients with hyperthyroidism. Nevertheless, the patients treated with thyroxine only rarely showed signs or symptoms of toxicity. It 
Results
Figures 1 and 2 show the data in graphical form. The serum concentration of total thyroxine in these clinically euthyroid subjects ranged from 75 to 222 nmol/l, mean 135, SD 31; normal range 60-150 nmol/l (5 8-17 2 ug/100 ml, mean 10 5, SD 2 4; normal range 4 7-117,ug/100 ml) and concentration of total triiodothyronine ranged from 1 5 to 3 3 nmol/l, mean 2-3, SD 0 37; normal range 1 2-3 1 nmol/ 1 (097-2 15 ng/ml, mean 1-5, SD 0-24; normal range 0 78-2 02 ng/ml). The concentrations of free thyroxine varied from 9 to 60 pmol/l, mean 22 7, SD 10 7; normal range 6-22 pmol/l (0 69 and 4 66 ng/ 100 ml, mean 1 76, SD 0-83; normal range 0 46-1 71 ng/100 ml) and concentration of free triiodothyronine was from 3 7 to 10-4 pmol/l, mean 5 9, SD 1 5; normal range 2-8-8-7 pmol/l (2 41-6-77 pg/ml, mean 3-8, SD 0-9; normal range 1-8-5-7 pg/ml). In all these patients the secretion of thyroid stimulating hormone was normal or suppressed (<4 0 mU/l).
The correlation coefficient between total and free thyroxine concentrations was 0-54 (free thyroxine pmol/= 0 179 total thyroxine nmol/l-2 06) and between concentrations of total and free triiodothyronine the correlation coefficient was 0-46 (free triiodothyronine pmol/l = 1 86 total triiodothyronine nmol/l + 1 53). The corresponding linear correlation coefficient between concentrations of total thyroxine and total triiodothyronine (fig 1) In the present study concentrations of both total and free thyroxine and triidothyronine have been measured in serum from a large number of healthy subjects who had hypothyroidism and were stabilised by treatment with thyroxine. As secretion of thyroid stimulating hormone was subdued in all any possible residual secretion of triiodothyronine by the thyroid was presumed to be negligible. In 39 subjects (32%) the total thyroxine concentration was raised, often to considerably above the upper limit of normal, a common finding even in patients maintained on the now conventional dosage of thyroxine, but in only five of these patients was total triiodothyronine marginally above the normal range (fig 1) . If the total concentration of thyroxine is high the occupancy of binding sites on thyroxine binding globulin will be increased, and the less strongly bound triiodothyronine may be displaced; a high total thyroxine concentration, therefore, might cause both an increase in free thyroxine and free triiodothyronine concentrations despite normal concentrations 3-5. of total triiodothyronine. This was not found to be the case. In 52 subjects the free thyroxine concentration was raised, often considerably (fig 2) , yet in only eight was the free triiodothyronine concentration slightly raised. Although statistical analysis of the data yielded significant correlations between total thyroxine and total triiodothyronine concentrations and between free thyroxine and free triiodothyronine concentrations, the slopes of the lines of the regression equations describing these correlations were small-that is, large increases in total and free thyroxine concentrations were accompanied by only modest increases in total and free triiodothyronine concentrations. These findings are in broad agreement with those of an earlier study of concentrations of free thyroid hormones, measured by a different technique in a smaller group of patients taking thyroxine. 10 The authors of this study suggested that supraphysiological free thyroxine concentrations were not harmful because free triiodothyronine was maintained within normal limits by a modulation of the peripheral reactions of deiodination. We urge caution, however, in extrapolating from data on serum concentration to inferences concerning the kinetics of the metabolism of thyroxine. Whether or not production of triiodothyronine at high concentrations of thyroxine is controlled to maintain a relatively normal free triiodothyronine concentration can be decided only by the appropriate kinetic experiments. Whatever the underlying explanation, the main practical conclusion is clear-namely, that supraphysiological free thyroxine concentrations are not necessarily accompanied by an increase in the free triiodothyronine concentration above the normal range.
What is the relevance of these findings ? It is the common experience that no characteristic pathology develops in patients treated for hypothyroidism even after many years, nor is life expectancy diminished. Moreover, this knowledge is derived from a period when larger doses of thyroid hormones were given than are now customary. It seems, therefore, that though physiological measurements in such patients can show evidence for overexposure to thyroid hormones,2 11 there are no deleterious biological consequences of this lack of fine tuning of dosage. This is in distinct contrast to the findings in insulin dependent diabetes, but in insulin dependent diabetes the hormone is immediately effective and does not require activation in peripheral tissues. It seems from measurements of concentrations of free thyroid hormone that there is a safe latitude in dosage of thyroxine. In our experience the discovery of high total thyroxine concentrations in otherwise well subjects with hypothyroidism who are taking thyroxine often generates unwarranted concern in both doctor and patient. Though it may well be prudent to reduce the dose in a patient whose concentration of total or free thyroxine is considerably raised, because the free triiodothyronine concentration may thus also be somewhat increased, few such patients show symptoms or signs of hyperthyroidism.
The past decade has witnessed an extraordinary proliferation in the number and variety of in vitro thyroid function tests available to the clinician, and the hard pressed general physician might with some justification deprecate the introduction of yet another. There has been a logic behind the development of these assays, however, based on two central tenets of thyroid physiology; firstly, the fact that the thyroid hormones are almost totally protein bound in the serum, and the minute free fraction is the physiologically important moiety, and secondly, the concept of thyroxine as an inactive prohormone, requiring conversion to triiodothyronine before a thyromimetic effect is seen. Since the protein bound iodine was displaced by the advent of radioimmunoassay for total thyroxine concentration, there have been introduced successively a free thyroxine index, total thyroxine related to thyroxine binding globulin, assays for total triiodothyronine concentrations, free thyroxine concentrations, and now free triiodothyronine concentrations. The data described in this paper suggest that in the assessment of patients receiving treatment with thyroxine, the most helpful investigations are those showing normal concentrations of thyroid stimulating hormone-that is, sufficient replacement-and those showing normal free triiodothyronine concentration (dosage not excessive). What is still required, however, is a single, simple, sensitive, and specific index of thyroid hormone activity at the tissue level; in the meantime the physician must select those investigations that seem most appropriate in the clinical context, and perhaps make greater use of the oldest thyroid test of all-the careful history and examination of the patient.
